200
Participants
Start Date
April 1, 2018
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2027
Combined chemotherapy with or without involved-field radiotherapy
Patients in low risk group receive 4 cycles of AVE-PC with or without involved-field radiotherapy (IFRT). Patients in intermediate risk group4 cycles ABVE-PC with or without IFRT. RERs in high risk group receive 4 cycles of ABVE-PC followed by followed by IFRT. SERs in high risk group receive 2 cycles of ABVE-PC followed by 2 cycles of IFOS/VINO and 2 cycles of ABVE-PC then followed by IFRT. IFRT consists of 21 Gy in 14 fractions of 1.5 Gy per day and is scheduled within 4 weeks after chemotherapy.
RECRUITING
Shanghai Children's Medical Center, Shanghai
RECRUITING
West China Second University Hospital, Sichuan University, Chengdu, China, Chengdu
RECRUITING
Nanjing Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China, Nanjing
Shanghai Children's Medical Center
OTHER
Children's Cancer Group, China
NETWORK